Structure and dynamics of membrane microdomains used for viral entry and egress
用于病毒出入的膜微域的结构和动力学
基本信息
- 批准号:7999969
- 负责人:
- 金额:$ 8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-01-07 至 2010-12-30
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesAntigensArtsAvidityBedsBindingBiological ModelsC Type Lectin ReceptorsCD209 geneCaliberCell membraneCell surfaceCell-Adhesion Molecule ReceptorsCellsCellular MembraneDC-specific ICAM-3 grabbing nonintegrinDendritic CellsElectron MicroscopyEnvironmentExhibitsFibroblastsGaggingGoalsGrantHIVHIV InfectionsHIV-1HeterogeneityImageImaging technologyImmune responseIndividualInfectionInfluenzaInfluenza HemagglutininIntegral Membrane ProteinLabelLateralLifeLigand BindingLigandsLigationLightLipidsMaintenanceMeasuresMembraneMembrane LipidsMembrane MicrodomainsMethodologyMethodsMicrobeMicroscopyMolecularMolecular BiologyMutationNaturePhotobleachingProcessPropertyProtein PrecursorsQuantum DotsSignal TransductionSiteSmall Interfering RNAStagingStructureSurfaceTechniquesTechnologyTestingViralVirionVirusVirus AssemblyVirus DiseasesVirus-like particlebasecell fixingcellular imaginggag Gene Productshuman PHEMX proteinmolecular dynamicsmutantnanoassaynew therapeutic targetparticlepathogenpublic health relevancereceptortoolvaccine development
项目摘要
DESCRIPTION (provided by applicant): This proposal represents a shift in direction from basic membrane domain studies in model and biological membranes in the previous grant to a commanding health-related problem, HIV infection, with strong connections to membrane lateral heterogeneity. Our overall goal is to apply cutting edge imaging technologies for the living cell to elucidate those aspects of virus infectivity that depend crucially on dynamic domains in the plasma membrane. In Specific Aim I, using molecular biology and lipid manipulation techniques in combination with live cell imaging, we will ask what molecular factors promote formation and stabilization of microdomains of influenza hemeagglutinin, HA, expressed in fibroblasts. This combined approach will provide live cell nanoassays for molecular interactions important in domain assembly and stability. Aim II will focus on the C-type lectin receptor DC-SIGN (CD209) which is expressed on the surface of Dendritic Cells (DC) where it functions as an antigen capture receptor and cell adhesion molecule. Various microbes, including HIV-1, bind to DC-SIGN to gain entry into DC. Previous studies using fixed cells demonstrated that DC-SIGN forms discrete antigen-capture clusters of 100-200 nm diameter on immature DC in the absence of any receptor ligation. We will study DC-SIGN clusters on living cells where detailed analysis of their dynamic properties--when loaded with different cargos--can be pursued. We will test the hypothesis that a key initial step in viral infection involves DC- SIGN clusters that, when loaded with pathogen cargo, are triggered to undergo directed lateral transport to sites of further processing by the host cell. Aim III will focus on microdomains that contain multiple components including the HIV-1 Gag polyprotein and a class of transmembrane proteins, the tetraspanins. We will test the hypothesis that the initial stages of virus assembly require Gag multimers to localize to tetraspanin-enriched microdomains and, once there, form stable clusters that will become sites of viral budding. PUBLIC HEALTH RELEVANCE The health-related significance of this proposal is based on the fact that effective, long-lasting strategies to thwart productive HIV-1 infection have remained elusive. The overwhelming majority of vaccine development has focused on the traditional methods of modifying the virus to elicit an immune response but this has been problematic because HIV-1 maintains one of the highest mutation rates amongst all viruses. As a result, increasing efforts have been focused on understanding how the virus interacts with its host cell with the ultimate goal of therapeutically disrupting these interactions. Cellular membrane microdomains are critical to the life of HIV-1 in cells in that the virus relies on their specific spatial arrangements for both entry into and exit out of target cells. Detailed information obtained in this grant on such membrane domains in the host cell will provide a better understanding of certain steps in HIV infection, thereby leading to new therapeutic targets.
描述(由申请人提供):该提案代表了一个方向的转变,从以前的资助中对模型和生物膜的基本膜域研究转向了一个与健康相关的重大问题,HIV感染,与膜侧异质性有很强的联系。我们的总体目标是应用最先进的活细胞成像技术来阐明病毒传染性的那些方面,这些方面在很大程度上取决于质膜中的动态结构域。在Specific Aim I中,使用分子生物学和脂质处理技术结合活细胞成像,我们将询问哪些分子因子促进成纤维细胞中表达的流感血凝素(HA)微域的形成和稳定。这种结合的方法将为在结构域组装和稳定性中重要的分子相互作用提供活细胞纳米测定。Aim II将重点关注c型凝集素受体DC- sign (CD209),它在树突状细胞(DC)表面表达,在那里它作为抗原捕获受体和细胞粘附分子起作用。包括HIV-1在内的各种微生物结合DC- sign进入DC。先前使用固定细胞的研究表明,在没有任何受体连接的情况下,DC- sign在未成熟的DC上形成直径为100- 200nm的离散抗原捕获簇。我们将在活细胞上研究DC-SIGN集群,在那里可以对它们的动态特性进行详细分析——当装载不同的货物时。我们将验证一个假设,即病毒感染的关键初始步骤涉及DC- SIGN集群,当装载病原体货物时,该集群被触发进行定向横向运输到宿主细胞进一步加工的位点。Aim III将重点关注包含多种成分的微结构域,包括HIV-1 Gag多蛋白和一类跨膜蛋白,四跨蛋白。我们将验证病毒组装的初始阶段需要Gag多聚子定位到富含四聚氰胺的微域,一旦在那里,形成稳定的簇,将成为病毒出芽的地点。这一建议的健康相关意义是基于这样一个事实,即有效、持久的战略,以阻止生产性艾滋病毒-1感染仍然难以捉摸。绝大多数疫苗开发都集中在修改病毒以引起免疫反应的传统方法上,但这一直存在问题,因为HIV-1在所有病毒中保持着最高的突变率之一。因此,越来越多的努力集中在了解病毒如何与宿主细胞相互作用上,最终目标是在治疗上破坏这些相互作用。细胞膜微结构域对HIV-1在细胞中的生存至关重要,因为病毒依靠其特定的空间安排进入和退出靶细胞。在这项资助中获得的关于宿主细胞中这些膜结构域的详细信息将提供对HIV感染的某些步骤的更好理解,从而导致新的治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kenneth A Jacobson其他文献
Kenneth A Jacobson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kenneth A Jacobson', 18)}}的其他基金
2004 Biophysical Discussion: Membrane Microdomains
2004 年生物物理讨论:膜微域
- 批准号:
6834500 - 财政年份:2004
- 资助金额:
$ 8万 - 项目类别:
REGULATION OF MOTILITY AND TRANSCRIPTION IN INFLAMMATION
炎症中运动和转录的调节
- 批准号:
6654106 - 财政年份:2002
- 资助金额:
$ 8万 - 项目类别:
REGULATION OF MOTILITY AND TRANSCRIPTION IN INFLAMMATION
炎症中运动和转录的调节
- 批准号:
6644954 - 财政年份:2001
- 资助金额:
$ 8万 - 项目类别:
REGULATION OF MOTILITY AND TRANSCRIPTION IN INFLAMMATION
炎症中运动和转录的调节
- 批准号:
6300943 - 财政年份:1999
- 资助金额:
$ 8万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 8万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 8万 - 项目类别: